These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31771334)

  • 1. An Evaluation of Risperidone Dosing for Pediatric Delirium in Children Less Than or Equal to 2 Years of Age.
    Campbell CT; Grey E; Munoz-Pareja J; Manasco KB
    Ann Pharmacother; 2020 May; 54(5):464-469. PubMed ID: 31771334
    [No Abstract]   [Full Text] [Related]  

  • 2. Risperidone in the treatment of delirium: results from a prospective open-label trial.
    Mittal D; Jimerson NA; Neely EP; Johnson WD; Kennedy RE; Torres RA; Nasrallah HA
    J Clin Psychiatry; 2004 May; 65(5):662-7. PubMed ID: 15163252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial.
    Agar MR; Lawlor PG; Quinn S; Draper B; Caplan GA; Rowett D; Sanderson C; Hardy J; Le B; Eckermann S; McCaffrey N; Devilee L; Fazekas B; Hill M; Currow DC
    JAMA Intern Med; 2017 Jan; 177(1):34-42. PubMed ID: 27918778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone in the treatment of patients with delirium.
    Parellada E; Baeza I; de Pablo J; Martínez G
    J Clin Psychiatry; 2004 Mar; 65(3):348-53. PubMed ID: 15096074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atypical antipsychotic medications to control symptoms of delirium in children and adolescents.
    Turkel SB; Jacobson J; Munzig E; Tavaré CJ
    J Child Adolesc Psychopharmacol; 2012 Apr; 22(2):126-30. PubMed ID: 22364403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating delirium in a general hospital: a descriptive study of prescribing patterns and outcomes.
    Briskman I; Dubinski R; Barak Y
    Int Psychogeriatr; 2010 Mar; 22(2):328-31. PubMed ID: 19785917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of risperidone in treating the hyperactive symptoms of delirium.
    Liu CY; Juang YY; Liang HY; Lin NC; Yeh EK
    Int Clin Psychopharmacol; 2004 May; 19(3):165-8. PubMed ID: 15107660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of different dosing regimens of risperidone and olanzapine in schizophrenia.
    Takeuchi H; Fervaha G; Lee J; Agid O; Remington G
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):295-302. PubMed ID: 25649680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnosis and management of delirium in infancy.
    Turkel SB; Jacobson JR; Tavaré CJ
    J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):352-6. PubMed ID: 23782129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Safety of Quetiapine in Treating Delirium in Critically Ill Children: A Retrospective Review.
    Joyce C; Witcher R; Herrup E; Kaur S; Mendez-Rico E; Silver G; Greenwald BM; Traube C
    J Child Adolesc Psychopharmacol; 2015 Nov; 25(9):666-70. PubMed ID: 26469214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of atypical antipsychotic prescribing in the intensive care unit.
    Kram BL; Kram SJ; Brooks KR
    J Crit Care; 2015 Aug; 30(4):814-8. PubMed ID: 25887805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring Haloperidol Plasma Concentration and Associated Adverse Events in Critically Ill Children With Delirium: First Results of a Clinical Protocol Aimed to Monitor Efficacy and Safety.
    Slooff VD; van den Dungen DK; van Beusekom BS; Jessurun N; Ista E; Tibboel D; de Wildt SN
    Pediatr Crit Care Med; 2018 Feb; 19(2):e112-e119. PubMed ID: 29239979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotics for delirium.
    Lonergan E; Britton AM; Luxenberg J; Wyller T
    Cochrane Database Syst Rev; 2007 Apr; (2):CD005594. PubMed ID: 17443602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the risk of adverse events between risperidone and haloperidol in delirium patients.
    Miyaji S; Yamamoto K; Hoshino S; Yamamoto H; Sakai Y; Miyaoka H
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):275-82. PubMed ID: 17472596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone dosing pattern and clinical outcome in psychosis: an analysis of 1713 cases.
    Kim CY; Shin YW; Joo YH; Hong JP; Lee GH; Choi SK
    J Clin Psychiatry; 2005 Jul; 66(7):887-93. PubMed ID: 16013904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged delirium managed with risperidone.
    Bourgeois JA; Hilty DM
    Psychosomatics; 2005; 46(1):90-1. PubMed ID: 15765831
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of risperidone in delirium: case reports.
    Sipahimalani A; Masand PS
    Ann Clin Psychiatry; 1997 Jun; 9(2):105-7. PubMed ID: 9242897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between plasma concentration levels of risperidone and clinical effects in the treatment of delirium.
    Toda H; Kusumi I; Sasaki Y; Ito K; Koyama T
    Int Clin Psychopharmacol; 2005 Nov; 20(6):331-3. PubMed ID: 16192843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic equivalence of risperidone given once daily and twice daily in patients with schizophrenia. The Risperidone Study Group.
    Nair NP
    J Clin Psychopharmacol; 1998 Apr; 18(2):103-10. PubMed ID: 9555595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotics and dopamine transporter gene polymorphisms in delirium patients.
    Kim JY; Jung IK; Han C; Cho SH; Kim L; Kim SH; Lee BH; Lee HJ; Kim YK
    Psychiatry Clin Neurosci; 2005 Apr; 59(2):183-8. PubMed ID: 15823165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.